Industry

Silence Therapeutics to Participate in Fireside Chat at Chardan Genetic Medicines Conference

LONDON–(BUSINESS WIRE)–$SLN #SenseofSilence–Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today announced that Giles Campion, MD, Head of R&D and Chief Medical Officer, will participate in a fireside … [Read more…]

Merck’s KEYTRUDA® (pembrolizumab) Receives Four New Approvals in Japan, Including in High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC)

KEYTRUDA now approved for 23 uses in 13 different types of cancer in Japan RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that KEYTRUDA, Merck’s anti-PD-1 therapy, received four new approvals from Japan’s Ministry of Health, Labor and Welfare (MHLW): KEYTRUDA in combination with chemotherapy … [Read more…]

BizCap® Secures $45 Million Credit Facility for Nivagen Pharmaceuticals

SAN FRANCISCO–(BUSINESS WIRE)–BizCap®, a national commercial finance and advisory firm, today announced it has successfully structured and secured $45 million in financing for its repeat client, Nivagen Pharmaceuticals, a specialty pharmaceuticals company engaged in the development, acquisition and sales of generic prescription drugs and over the counter products for the North American market. The credit … [Read more…]

Global Rehabilitation Robotics Market Report 2022 – Featuring Cyberdyne, ReWalk Robotics, Ekso Bionics and Rex Bionics Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Rehabilitation Robotics Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the global rehabilitation robotics market. The global rehabilitation robotics market is expected to grow from $0.8 billion in 2021 to $0.96 billion in 2022 … [Read more…]

LetsGetChecked Introduces myPGx, a Pharmacogenomics Solution that Leverages the Power of Precision Medicine to Improve Patient Health with More Tailored Treatment Plans

myPGx is the debut launch of LetsGetChecked’s new suite of genetics offerings, pioneering a full lifecycle of personalized, 360-degree healthcare from home NEW YORK–(BUSINESS WIRE)–LetsGetChecked, a leading healthcare solutions company, announced today the launch of its inaugural genetics offering, myPGx, a pharmacogenomics solution. myPGx enables prescribers to select medications with greater expectation of efficacy and … [Read more…]

Ocular Therapeutix™ Announces Interim 7-month Data from U.S. Phase 1 Clinical Trial of OTX-TKI for the Treatment of Wet AMD

OTX-TKI was Well Tolerated and Demonstrated a Favorable Safety Profile with no Drug-Related Ocular or Systemic Serious Adverse Events (SAEs) Sustained and Comparable CSFT and BCVA Measurements at 7 Months between OTK-TKI Treated Subjects and Aflibercept Treated Subjects 80% of Subjects were Rescue-Free up to 6 months and 73% of Subjects Were Rescue-Free up to … [Read more…]

Insights on the Artificial Organs and Medical Bionics Global Market to 2027 – Asia Pacific Advanced to Forefront of Global Market with Steady Rise in Surgical Procedures and Healthcare Expenditure – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Artificial Organs and Medical Bionics Market – Global Industry Analysis (2019 – 2021) – Growth Trends and Market Forecast (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The world is witnessing a massive gap between the demand and supply imbalance of human organs. Notably, organ donors are far fewer than patients … [Read more…]

2022 Global Lung Cancer Clinical Trial Pipeline Highlights Report: Up-to-date Information on Key Pipeline Products – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Lung Cancer Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. This report provides the most up-to-date information on key pipeline products within the global Lung Cancer market. It covers emerging therapies for Lung Cancer in active clinical development stages including early and late stage clinical trials. The … [Read more…]

EVER Pharma Launches the User-friendly D-mine® Pump Generated Report “DATA-mine®” to Enhance the Therapy Management of Parkinson’s Patients on Apomorphine

SALZBURG, Austria–(BUSINESS WIRE)–#dminecare—After successfully launching the D-mine® Pump, a micro infusion device designed to provide precise continuous subcutaneous drug delivery for PD patients, the product family has been extended to include a comprehensive data history readout. EVER Pharma, a specialist in neurology and specialty pharmaceuticals, offers a complete therapy package for PD patients with Dacepton® … [Read more…]

Four out of ten Canadians report significant gap between culture their workplace claims to have versus their reality

Supported by TELUS Health, LifeWorks’ Mental Health Index™ finds negative workplace culture impacts mental health and leads to three times less productivity than positive environments TORONTO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total wellbeing solutions supported by TELUS Health, today released its monthly Mental Health Index™ revealing that four out of 10 (38 … [Read more…]